Literature DB >> 26255225

A simple bioscore improves diagnostic accuracy of sepsis after surgery.

Zimeng Liu1, Juan Chen1, Yongjun Liu1, Xiang Si1, Zhiyi Jiang1, Xuyu Zhang2, Xiangdong Guan3.   

Abstract

BACKGROUND: Rapid and accurate prediction for sepsis remains a challenge in surgical intensive care units. Detection of individual biomarkers is often of marginal usefulness, and several biomarkers are difficult to measure in the clinical setting. The aim of this study was to evaluate the diagnostic and prognostic performance of three routine biomarkers, procalcitonin (PCT), B-type natriuretic peptide (BNP), and lymphocyte percentage, as individual or in combination for sepsis in surgical critically ill patients.
MATERIALS AND METHODS: Circulating PCT, BNP, and lymphocyte percentage were measured in surgical patients on admission to the intensive care unit. A bioscore system combining these biomarkers was constructed. All studied variables were analyzed according to the diagnosis and clinical outcomes of sepsis.
RESULTS: A total of 320 consecutive patients were included in the analysis. One hundred fifty-six patients presented with sepsis. In the patients with sepsis, levels of PCT and BNP increased and lymphocyte percentage decreased. For individual biomarkers, PCT achieved the best area under the curve for the diagnosis of sepsis, whereas the diagnostic performance of the bioscore was better than that of each individual biomarker (area under the curve, 0.914 [95% confidence interval, 0.862-0.951]). Levels of BNP and bioscore increased in nonsurvivors in the entire cohort, but the accuracy of these two variables for mortality prediction was lower than that shown by Acute Physiology and Chronic Health Evaluation II score. Furthermore, bioscore failed to predict outcomes in septic patients.
CONCLUSIONS: A simple bioscore combining PCT together with BNP and lymphocyte percentage improves the diagnostic accuracy for sepsis in surgical critically ill patients but fails to predict outcomes in surgical patients with sepsis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-type natriuretic peptide; Diagnostic biomarkers; Lymphocyte; Procalcitonin; Prognostic biomarkers; Sepsis; Surgery

Mesh:

Substances:

Year:  2015        PMID: 26255225     DOI: 10.1016/j.jss.2015.07.022

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  'σήψις' yesterday, sepsis nowadays: what's changing?

Authors:  Salvatore Lucio Cutuli; Gennaro De Pascale; Massimo Antonelli
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 2.  AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital.

Authors:  Zhongheng Zhang; Nathan J Smischney; Haibo Zhang; Sven Van Poucke; Panagiotis Tsirigotis; Jordi Rello; Patrick M Honore; Win Sen Kuan; Juliet June Ray; Jiancang Zhou; You Shang; Yuetian Yu; Christian Jung; Chiara Robba; Fabio Silvio Taccone; Pietro Caironi; David Grimaldi; Stefan Hofer; George Dimopoulos; Marc Leone; Sang-Bum Hong; Mabrouk Bahloul; Laurent Argaud; Won Young Kim; Herbert D Spapen; Jose Rodolfo Rocco
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock.

Authors:  Govind Pandompatam; Kianoush Kashani; Saraschandra Vallabhajosyula
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14

Review 4.  Natriuretic Peptides to Predict Short-Term Mortality in Patients With Sepsis: A Systematic Review and Meta-analysis.

Authors:  Saarwaani Vallabhajosyula; Zhen Wang; M Hassan Murad; Shashaank Vallabhajosyula; Pranathi R Sundaragiri; Kianoush Kashani; Wayne L Miller; Allan S Jaffe; Saraschandra Vallabhajosyula
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-01-08

Review 5.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.